Position in GOSS
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,918,932
+$1,518,254 QoQ
Shares Held
11,629,896
+854.9% QoQ
Ownership
2.38%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#9
of 168 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GOSS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RENAISSANCE TECHNOLOGIES LLC holds $3,952,579,858 across 312 Biotechnology names. GOSS ranks #134 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | EXEL |
Exelixis, Inc.
|
13,427,993 | $730,617,099 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
5,261,628 | $457,498,554 | |
| 3 | INCY |
Incyte Corp
|
3,512,132 | $398,135,283 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
320,008 | $158,957,573 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
562,073 | $135,442,730 | |
| 6 | RPRX |
Royalty Pharma plc
|
1,935,800 | $108,540,306 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,833,079 | $104,137,217 | |
| 8 | GMAB |
Genmab A/S
|
3,517,850 | $96,635,339 |
All Filings in GOSS
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,918,932 | 11,629,896 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $400,678 | 1,217,868 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,042,552 | 658,888 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,837,894 | 2,980,188 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $3,360,721 | 2,732,294 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,726,070 | 1,569,155 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,549,815 | 1,712,503 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,720,377 | 1,744,805 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,843,986 | 2,046,600 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $792,488 | 671,600 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $910,261 | 997,001 | Shares | Sole | 2024-02-13 | |
| 2022-09-30 | $428,884 | 35,800 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $576,693 | 68,900 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $1,146,628 | 132,100 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $494,247 | 43,700 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $1,387,500 | 150,000 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $1,767,676 | 182,800 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $4,164,796 | 335,600 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,726,800 | 363,600 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $989,239 | 97,462 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||